Dermoscopic features of melanomas associated with MC1R variants in Spanish CDKN2A mutation carriers

British Journal of Dermatology

Volumn 160, Issue 1, 2009, Pages 48-53

  Cuellar F ^a,b   Puig, S ^a,c   Kolm, I ^a   Puig Butille, J ^a,c   Zaballos, P ^d   Marti Laborda R ^e   Badenas, C ^a,c   Malvehy, J ^a,c  

^a HOSPITAL CLÍNIC   (Spain)

^b Unidad Durango   (Mexico)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d Hospital Sant Pau i Santa Tecla   (Spain)

^e HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

CDKN2A; Dermoscopy; MC1R; Melanoma; Red hair; Total dermoscopy score

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; MELANOCORTIN 1 RECEPTOR;

ADULT; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HETEROZYGOTE; HUMAN; MALE; MELANOMA; PRIORITY JOURNAL; SPAIN;

ADULT; AGE FACTORS; DERMOSCOPY; FEMALE; GENES, P16; GENETIC VARIATION; GENOTYPE; HAIR COLOR; HUMANS; MALE; MELANOMA; MIDDLE AGED; PEDIGREE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTOR, MELANOCORTIN, TYPE 1; SKIN NEOPLASMS; SPAIN; YOUNG ADULT;

EID: 57649227248     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2008.08826.x     Document Type: Article

References (28)

1. Bosetti C, La Vecchia C, Naldi L et al. Mortality from cutaneous malignant melanoma in Europe. Has the epidemic levelled off? Melanoma Res 2004 14 : 301 9.
2. de Vries E, Coebergh JW. Cutaneous malignant melanoma in Europe. Eur J Cancer 2004 40 : 2355 66.
3. Goldstein AM, Tucker MA. Etiology, epidemiology, risk factors, and public health issues of melanoma. Curr Opin Oncol 1993 5 : 358 63.
4. Sturm RA, Box NF, Ramsay M. Human pigmentation genetics: the difference is only skin deep. Bioessays 1998 20 : 712 21.
5. Rees JL. The melanocortin1 receptor (MC1R): more than just red hair. Pigment Cell Res 2000 13 : 135 40.
6. Flanagan N, Healy E, Ray A et al. Pleiotropic effects of the melanocortin 1 receptor (MC1R) gene on human pigmentation. Hum Mol Genet 2000 9 : 2531 7.
7. Kennedy C, ter Huurne J, Berkhout M et al. Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 2001 117 : 294 300.
8. Duffy DL, Box NF, Chen W et al. Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 2004 13 : 447 61.
9. Box NF, Duffy DL, Chen W et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001 69 : 765 73.
10. van der Velden PA, Sandkuijl LA, Bergman W et al. Melanocortin-1 receptor variant R151C modifies melanoma risk in Dutch families with melanoma. Am J Hum Genet 2001 69 : 774 9.
11. Goldstein AM, Landi MT, Tsang S et al. Association of MC1R variants and risk of melanoma in melanoma-prone families with CDKN2A mutations. Cancer Epidemiol Biomarkers Prev 2005 14 : 2208 12.
12. Rees JL. Genetics of hair and skin color. Annu Rev Genet 2003 37 : 67 90.
13. Shriver MD, Parra EJ, Dios S et al. Skin pigmentation, biogeographical ancestry and admixture mapping. Hum Genet 2003 112 : 387 99.
14. Benelli C, Roscetti E, Pozzo VD et al. The dermoscopic versus the clinical diagnosis of melanoma. Eur J Dermatol 1999 9 : 470 6.
15. Bafounta ML, Beauchet A, Aegerter P et al. Is dermoscopy (epiluminescence microscopy) useful for the diagnosis of melanomas? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001 137 : 1343 50.
16. Ascierto PA, Palmieri G, Celentano E et al. Sensitivity and specificity of epiluminescence microscopy: evaluation on a sample of 2731 excised cutaneous pigmented lesions. Br J Dermatol 2000 142 : 893 8.
17. Skavara H, Teban L, Fiebiger M et al. Limitations of dermoscopy in the recognition of melanoma. Arch Dermatol 2005 141 : 155 60.
18. Pizzichetta MA, Talamini R, Stanganelli I et al. Amelanotic/hypomelanotic melanoma: clinical and dermoscopic features. Br J Dermatol 2004 150 : 1117 24.
19. Puig S, Ruiz A, Castel T et al. Inherited susceptibility to several cancers but absence of linkage between dysplastic nevus syndrome and CDKN2A in a melanoma family with a mutation in the CDKN2A (p16INK4A) gene. Hum Genet 1997 101 : 359 64.
20. Puig S, Malvehy J, Badenas C et al. Role of the CDKN2A locus in patients with multiple primary melanomas. J Clin Oncol 2005 23 : 3043 51.
21. Badenas C, Torra R, San Millán JL et al. Mutational analysis within the 3′ region of the PKD1 gene. Kidney Int 1999 55 : 1225 33.
22. den Dunnen JT, Antonarakis E. Mutation nomenclature extensions and suggestions to describe complex mutations: a discusssion. Hum Mutat 2000 15 : 7 12.
23. Stolz W, Riemann A, Cognetta AB et al. ABCD rule of dermatoscopy: a new practical method for early recognition of malignant melanoma. Eur J Dermatol 1994 4 : 521 7.
24. Nachbar F, Stolz W, Merkle T et al. The ABCD rule of dermatoscopy: high prospective value in diagnosis of melanocytic lesions. J Am Acad Dermatol 1994 30 : 551 9.
25. Giuliano AE, Cochran AJ, Morton DL. Melanoma from unknown primary site and amelanotic melanoma. Semin Oncol 1982 9 : 442 7.
26. Malvehy J, Puig S. Follow-up of melanocytic skin lesions with digital total-body photography and digital dermoscopy: a two-step method. Clin Dermatol 2002 20 : 297 304.
27. Puig S, Argenziano G, Zalaudek I et al. Melanomas that failed dermoscopic detection: a combined clinicodermoscopic approach for not missing melanoma. Dermatol Surg 2007 33 : 1262 73.
28. Ascierto PA, Palmieri G, Botti G et al. Melanoma Cooperative Group. Early diagnosis of malignant melanoma: proposal of a working formulation for the management of cutaneous pigmented lesions from the Melanoma Cooperative Group. Int J Oncol 2003 22 : 1209 15.